Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Study backs cochlear implant use in children:

This article was originally published in Clinica

Executive Summary

More evidence that the younger that deaf and hearing-impaired children receive cochlear implants, the better they perform in speech recognition tests later in life, has come from a 101-patient US study published in the January issue of Otology and Neurotology. The study, performed at the University of Michigan Health System in Ann Arbor, showed that the biggest difference was between seven-year-old children who had had their implant for four or more years and children aged five to seven who had had theirs for only three years. The FDA has approved cochlear implants for use in children as young as 12 months and clinical trials in children aged 12-24 months are underway.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT069486

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel